Skip to main content

The Globe and Mail

Health Canada approves non-prescription naloxone nasal spray

Health Minister Jane Philpott has authorized naloxone nasal spray for non-prescription use.

Hand-out/Adapt Pharma

Health Minister Jane Philpott has authorized naloxone nasal spray for non-prescription use to help prevent deaths from opioid overdoses.

Naloxone, sold under the brand name Narcan, can reverse the effects of an opioid overdose if used promptly.

Monday's move follows an interim order by Philpott in July that allowed naloxone nasal spray to be imported from the U.S. Only the injectable version of the drug had been approved in Canada.

Story continues below advertisement

The nasal spray is considered easier to administer than the injectable version, especially for those who aren't trained health-care professionals.

Health Canada says the nasal spray's manufacturer can now take the necessary steps to officially bring the product to market in Canada.

Until then, the U.S.-approved product will continue to be available in Canada to avoid interruption in supply.

Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨